Skip to content
MedsAcross

Alternatives

Alternatives to Umeclidinium and Vilanterol Ellipta 62.5 mcg/25 mcg inhalation powder

1 other presentations of Umeclidinium and Vilanterol 62.5 mcg/25 mcg inhalation powder

There are 1 alternatives to this medicine in the catalogue: the same active ingredient (Umeclidinium and Vilanterol), strength (62.5 mcg/25 mcg) and dosage form (inhalation powder) from 1 other makers or registers. The table compares packs, storage, lead time, documents and availability.

Side by side

The first row is the medicine you came from.

MedicineManufacturerRegisterPacksStorageLead timeDocumentsAvailability
Umeclidinium and Vilanterol Ellipta 62.5 mcg/25 mcg inhalation powderThis pageInhalationPrasco LaboratoriesUS FDA1 trayStore at room temperature between 68°F and 77°F (20°C and 25°C), excursions permitted from 59°F to 86°F (15°C to 30°C). Store in a dry place away from direct heat or sunlight. Umeclidinium and Vilanterol ELLIPTA should be stored inside the unopened moisture-protective foil tray and only removed from the tray immediately before initial use.On request—Available on request
Anoro Ellipta 62.5 mcg/25 mcg inhalation powderInhalationGlaxoSmithKlineUS FDA1 tray, 1 trayStore at room temperature between 68°F and 77°F (20°C and 25°C), excursions permitted from 59°F to 86°F (15°C to 30°C). Store in a dry place away from direct heat or sunlight. ANORO ELLIPTA should be stored inside the unopened moisture-protective foil tray and only removed from the tray immediately before initial use.On request—Available on request

Alternatives are listed for sourcing. Whether one medicine can replace another is the prescriber's decision, under the rules of the destination country.

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Back to Umeclidinium and Vilanterol Ellipta 62.5 mcg/25 mcg inhalation powder

Not sure which maker to choose?

Request a quote for the medicine and we will propose the options that fit your country's import rules and timelines.